Phibro Animal Health (PAHC) Depreciation & Amortization (CF) (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Depreciation & Amortization (CF) of $12.4 million for Q1 2026, down 1.33% year-over-year from $12.6 million in Q1 2025, and down 3.44% quarter-over-quarter from $12.9 million in Q4 2025.
Phibro Animal Health (PAHC) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends
Phibro Animal Health's Depreciation & Amortization (CF) history runs 14 years deep, the most recent figure standing at $12.4 million for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 1.33% year-over-year to $12.4 million; the TTM figure through Mar 2026 stood at $50.6 million (up 19.31% YoY), while the FY2025 annual figure was $45.6 million, up 26.06% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $12.4 million, down from $12.9 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $12.9 million in Q4 2025, with the low at $8.4 million in Q2 2022.
- The 5-year median for Depreciation & Amortization (CF) is $9.0 million (2024), against an average of $10.0 million.
- The sharpest annual moves came in 2022 and 2026: Depreciation & Amortization (CF) soared 168900.0% in 2022, then declined 1.33% in 2026.
- Phibro Animal Health's Depreciation & Amortization (CF) stood at $8.5 million in 2022, then climbed by 4.84% to $8.9 million in 2023, then increased by 29.9% to $11.6 million in 2024, then grew by 11.38% to $12.9 million in 2025, then declined by 3.44% to $12.4 million in 2026.
- Business Quant data shows PAHC's Depreciation & Amortization (CF) at $12.4 million in Q1 2026, $12.9 million in Q4 2025, and $12.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 125.68 Mn | 12.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.45 Mn |
| Mar 31, 2026 | 12.45 Mn |
| Dec 31, 2025 | 12.89 Mn |
| Dec 31, 2025 | 12.89 Mn |
| Sep 30, 2025 | 12.83 Mn |
| Sep 30, 2025 | 12.83 Mn |
| Jun 30, 2025 | 12.41 Mn |
| Jun 30, 2025 | 12.41 Mn |
| Mar 31, 2025 | 12.62 Mn |
| Mar 31, 2025 | 12.62 Mn |
| Dec 31, 2024 | 11.57 Mn |
| Dec 31, 2024 | 11.57 Mn |
| Sep 30, 2024 | 9.00 Mn |
| Sep 30, 2024 | 9.00 Mn |
| Jun 30, 2024 | 9.20 Mn |
| Jun 30, 2024 | 9.20 Mn |
| Mar 31, 2024 | 9.20 Mn |
| Mar 31, 2024 | 9.20 Mn |
| Dec 31, 2023 | 8.91 Mn |
| Dec 31, 2023 | 8.91 Mn |